When chronically stimulated, T cells can enter an exhausted state where they cease effector functions. This is especially important in cancer, where T cells function abnormally upon activation and can differentiate into a terminally dysfunctional state upon continued tumor exposure. In this webinar from The Scientist, Mary Philip and Benjamin Youngblood will discuss how T cell exhaustion is defined, its causes and drivers, and how it affects cell responses to immunotherapies.
Topics to be covered
T cell dysfunction and exhaustion in cancer
Using epigenetic mechanisms of T cell exhaustion to enhance immunotherapy
Friday, March 11, 2022
2:30 - 4:00 PM Eastern Time
This webinar will also be available on-demand.
Meet the speakers
Mary Philip, MD, PhD Assistant Professor Department of Medicine/Division of Hematology-Oncology Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center
Benjamin Youngblood, PhD Associate Member
Department of Immunology St. Jude Children’s Research Hospital
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: email@example.com